Alalami, H., Rudnick, J. D., Wilson, J., Guevarra, A., Naor, R., Hu, J. L. (2025). Real-world experience with vorasidenib in IDH-mutant gliomas: Tolerability, adverse events, and access in patients who did not meet INDIGO trial eligibility criteria.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e14029